Department of Medicine
University of Pittsburgh
Select a Division
Cardiology
Center for Clinical Pharmacology
Endocrinology and Metabolism
Gastroenterology, Hepatology and Nutrition
General Internal Medicine
Geriatric Medicine
Hematology/Oncology
Infectious Diseases
Pulmonary, Allergy and Critical Care Medicine
Renal-Electrolyte
Rheumatology and Clinical Immunology
Academic Resources
Home
Division Faculty
Gastroenterology Career Tracks
Rotation Objectives
Fellowship Research Opportunities & T-32 Grant
Transplant Hepatology Fellowship
Current Fellows
Prospective Applicants
Life in Pittsburgh
Applying to our Program
Contact Us
Other Resources
Department of Medicine
Divisions of the Department
Internal Medicine Residency Training
2006 UPMC Annual Report
Video -"Pittsburgh. A New Vision. A New Tomorrow."
Division of Gastroenterology, Hepatology and Nutrition
Mezzanine Level,
C-Wing-PUH
200 Lothrop Street
Pittsburgh, PA 15261
Phone: (412) 648-9115
David G. Binion, MD
Visiting Professor of Medicine
Co-Director, Inflammatory Bowel Disease Center
Office:
Univ. of Pgh. Div. of GI, Hepatology & Nutr.
PUH, M2, C Wing - 200 Lothrop St.
Pittsburgh, PA 15213
Phone:
412-648-9115
Fax:
412-648-9378
E-mail:
biniond@upmc.edu
Education
AB - General Studies, Harvard College - Cambridge, MA, 1984
MD, State Univ. of New York at Buffalo - Buffalo, NY, 1988
Training
Research Fellow - Immunology, Cleveland Clinic Fdn. Research Inst. - Cleveland, OH, 1993
Internship & Residency, Rhode Island Hospital (Brown Univ.) - Providence, RI, 1991
Gastroenterology Fellowship, Univ. Hospitals of Cleveland (Case Western) - Cleveland, OH, 1993
Profile
Dr. Binion is an internationally recognized expert on Inflammatory Bowel Disease basic science, translational and clinical investigation. His research has been funded by the National Institutes of Health and the Crohn’s and Colitis Foundation of America. His investigation has centered on the cellular and molecular mechanisms of human IBD, with a specific focus on the microvascular biology of chronic intestinal inflammation. His clinical work has centered on developing novel therapies and algorithms for treatment of patients with severe and refractory IBD.